Premium
Movement disorders in Rett syndrome: An analysis of 60 patients with detected MECP2 mutation and correlation with mutation type
Author(s) -
Temudo Teresa,
Ramos Elisabete,
Dias Karin,
Barbot Clara,
Vieira Jose P.,
Moreira Ana,
Calado Eulalia,
Carrilho Ines,
Oliveira Guiomar,
Levy Antonio,
Fonseca Maria,
Cabral Alexandra,
Cabral Pedro,
Monteiro Joao P,
Borges Luis,
Gomes Roseli,
Santos Manuela,
Sequeiros Jorge,
Maciel Patricia
Publication year - 2008
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.22115
Subject(s) - rett syndrome , dystonia , mecp2 , movement disorders , frameshift mutation , chorea , missense mutation , ataxia , myoclonus , neurological disorder , medicine , nonsense mutation , pediatrics , psychology , disease , mutation , genetics , central nervous system disease , psychiatry , biology , gene , phenotype
Rett syndrome (RS) is one of the best human models to study movement disorders. Patients evolve from a hyperkinetic to a hypokinetic state, and a large series of abnormal movements may be observed along their lives such as stereotypies, tremor, chorea, myoclonus, ataxia, dystonia, and rigidity. The aim of this work was to analyze movement disorders in RS patients with a detected MECP2 mutation, as well as their correlation with genotype, in a clinically and genetically well‐characterized sample of patients, and thus contribute to redefine the clinical profile of this disease. In this study, we included 60 patients with detected MECP2 mutations. These were categorized and grouped for analysis, according to (1) type of change (missense or truncating, including nonsense and frameshift but also large deletions) and (2) location of the mutation. Differences were found concerning the frequency of independent gait, dystonia, type of tremor, and global score severity when comparing the group of patients with missense and truncating mutations. We also found differences in the presence, distribution, severity, or type of movement disorders in the two groups of patients according to the median duration of the disease (less than 60 months; 60 months or more). We conclude that movement disorders seem to reflect the severity and rate of progression of Rett disorder, patients with truncating mutations presenting a higher rate and more severe dystonia and rigid‐akinetic syndrome, when comparing groups with similar time of disease evolution. © 2008 Movement Disorder Society